Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug 28:11:71.
doi: 10.1186/1472-6882-11-71.

Stakeholders' perspectives on the regulation and integration of complementary and alternative medicine products in Lebanon: a qualitative study

Affiliations

Stakeholders' perspectives on the regulation and integration of complementary and alternative medicine products in Lebanon: a qualitative study

Mohamad Alameddine et al. BMC Complement Altern Med. .

Abstract

Background: The regulation of the markets for Complementary and Alternative Medicine (CAM) products presents a global challenge. There is a dearth of studies that have examined or evaluated the regulatory policies of CAM products in the Eastern Mediterranean Region (EMR). We investigate the regulatory frameworks and the barriers for the proper regulation and integration of CAM products in Lebanon, as an example of an EMR country with a weak public infrastructure.

Methods: We utilized a qualitative study design involving a series of semi-structured interviews with stakeholders of the CAM market in Lebanon. Snowball sampling was used to identify interviewees; interviews continued until the "saturation" point was reached. A total of 16 interviews were carried out with decision makers, representatives of professional associations, academic researchers, CAM product importers, policy makers and a media representative. Interviews were transcribed and thematic analysis of scripts was carried out.

Results: There was a consensus among all stakeholders that the regulation of the market for CAM products in Lebanon needs to be strengthened. Thematic analysis identified a number of impediments jeopardizing the safety of public consumption and hindering the integration of CAM therapies into mainstream medicine; including: weak infrastructure, poor regulation, ineffective policies and politics, weak CAM awareness and sub-optimal coordination and cooperation among stakeholders. With respect to policy instruments, voluntary instruments (self regulation) were deemed ineffective by stakeholders due to poor awareness of both users and providers on safe use of CAM products. Stakeholders' rather recommended the adoption of a combination of mixed (enhancing public awareness and integration of CAM into medical and nursing curricula) and compulsory (stricter governmental regulation) policy instruments for the regulation of the market for CAM products.

Conclusions: The current status quo with respect to the regulation of CAM products in Lebanon is not conducive to public safety, nor does it support the integration of CAM products into the healthcare system. The Ministry of Health indeed plays a dominant role in the regulation of these products through a combination of mixed and compulsory policy instruments. Yet, the proper implementation of these regulations requires political resolve coupled with the cooperation of all CAM stakeholders.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The CAM Review Process in Lebanon.
Figure 2
Figure 2
Distribution of Stakeholders by type and background.

Similar articles

Cited by

References

    1. NIH: National Center for Complementary and Alternative Medicine. http://nccam.nih.gov/health/whatiscam/
    1. Ernst E, Cassileth BR. How useful are unconventional cancer treatments? Eur J Cancer. 1999;35(11):1608–1613. doi: 10.1016/S0959-8049(99)00198-7. - DOI - PubMed
    1. Hoffman C. Integrated Medicine Conference Report: can alternative medicine be integrated into mainstream care? Complement Ther Nurs Midwifery. 2001;7(2):110–114. doi: 10.1054/ctnm.2001.0538. - DOI - PubMed
    1. Morrow JD. Why the United States still needs improved dietary supplement regulation and oversight. Clin Pharmacol Ther. 2008;83(3):391–393. doi: 10.1038/sj.clpt.6100500. - DOI - PubMed
    1. Harvey KJ, Korczak VS, Marron LJ, Newgreen DB. Commercialism, choice and consumer protection: regulation of complementary medicines in Australia. Med J Aust. 2008;188(1):21–25. - PubMed

Publication types

MeSH terms